Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Abcam’s mission is to help accelerate the next breakthrough in drug discovery, diagnostics and basic research. It accomplishes this...
— Brown Capital Management International All Company Fund
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Abcam plc
The manager discusses shareholder activism at Abcam that led management to launch a full strategic review of alternatives, including a potential sale. The ongoing governance...
Abcam provides life-science research supplies via an efficient e-commerce platform with high customer retention and long product life cycles. The fund successfully...
More institutional theses from Brown Capital Management International All Company Fund
The manager remains committed to their long-term growth thesis despite short-term margin compression driven by a weak high-margin product mix and higher procurement and labor costs. They believe the...
The manager reports that SimCorp agreed to be acquired by Deutsche Borse Group at a premium of nearly forty percent over its prior close. This cash acquisition...
The manager highlights the substantial growth runway of the company due to the relatively low e-commerce penetration rates throughout Latin America. Despite a temporary...